VTYX Company Profile and Key Details

Q: Who are the executives of VTYX?

Dr. John M. Nuss Ph.D.Chief Scientific OfficerProf. William J. Sandborn M.D., Ph.D.Pres & Chief Medical OfficerMr. Christopher W. Krueger J.D., MBAChief Bus. OfficerDr. Sheila K. Gujrathi M.D.Executive ChairpersonDr. Raju S. Mohan Ph.D.Founder, Chief Executive Officer & DirectorDr. William J. Sandborn M.D., Ph.D.Pres & Chief Medical OfficerDr. Martin Douglas Auster M.D.Chief Financial Officer

NASDAQ : VTYX

Ventyx Biosciences

$13.87

-0.01-0.07%

Open: 3:57 PM

58.95

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Ventyx Biosciences, Inc. (VTYX) stock declined over -0.07%, trading at $13.87 on NASDAQ, down from the previous close of $13.88. The stock opened at $13.88, fluctuating between $13.84 and $13.89 in the recent session.

Stock Snapshot

13.88

Prev. Close

995.17M

Market Cap

13.84

Day Low

-9.31

P/E Ratio

-1.49

EPS (TTM)

-2.83

Cash Flow per Share

13.88

Open

71.75M

Number of Shares

13.89

Day High

88.62%

Free Float in %

4.13

Book Value

2.95M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 20, 2026	13.86	13.88	13.85	13.88	2.19M
Jan 16, 2026	13.86	13.90	13.85	13.89	1.92M
Jan 15, 2026	13.86	13.88	13.84	13.86	1.2M
Jan 14, 2026	13.84	13.87	13.83	13.86	2.37M
Jan 13, 2026	13.82	13.87	13.82	13.86	4.28M
Jan 12, 2026	13.80	13.86	13.80	13.84	2.78M
Jan 09, 2026	13.83	13.83	13.78	13.81	12.98M
Jan 08, 2026	13.76	13.85	13.76	13.84	35.43M
Jan 07, 2026	15.32	15.34	13.43	13.73	26M
Jan 06, 2026	7.90	25.00	7.08	10.05	5.12M
Jan 05, 2026	8.51	8.55	7.70	7.82	1.31M
Jan 02, 2026	9.02	9.02	8.23	8.40	1.22M
Dec 31, 2025	8.77	9.30	8.72	9.03	590.81K
Dec 30, 2025	9.08	9.10	8.61	8.75	697.49K
Dec 29, 2025	9.22	9.35	9.03	9.08	618.59K
Dec 26, 2025	9.17	9.34	8.98	9.26	488.63K
Dec 24, 2025	9.07	9.50	9.06	9.18	593.3K
Dec 23, 2025	9.34	9.53	8.86	9.07	683.49K
Dec 22, 2025	8.68	9.37	8.67	9.34	1.03M
Dec 19, 2025	7.80	8.92	7.78	8.74	2.83M

Contact Details

San Diego, CA 92024

United States

https://www.ventyxbio.com 760 593 4832

About Company

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.

Stock Peers

ARGX

9.63+1.20%

argenx SE$809.64 REGN

0.74+0.10%

Regeneron Pharmaceuticals, Inc.$733.78 MDGL

3.27+0.65%

Madrigal Pharmaceuticals, Inc.$504.95 UTHR

3.14+0.68%

United Therapeutics Corporation$468.07 VRTX

0.72+0.16%

Vertex Pharmaceuticals Incorporated$442.08 ALNY

-3.74-1.04%

Alnylam Pharmaceuticals, Inc.$355.53 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

6.83+2.15%

Praxis Precision Medicines, Inc.$324.08 KRYS

-10.23-3.59%

Krystal Biotech, Inc.$274.81 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Ventyx Biosciences, Inc. (VTYX) stock price?

Ventyx Biosciences, Inc. (NASDAQ: VTYX) stock price is $13.87 in the last trading session. During the trading session, VTYX stock reached the peak price of $13.89 while $13.84 was the lowest point it dropped to. The percentage change in VTYX stock occurred in the recent session was -0.07% while the dollar amount for the price change in VTYX stock was - $0.01.

VTYX's industry and sector of operation?

The NASDAQ listed VTYX is part of Biotechnology industry that operates in the broader Healthcare sector. Ventyx Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VTYX?

Dr. John M. Nuss Ph.D.
Chief Scientific Officer
Prof. William J. Sandborn M.D., Ph.D.
Pres & Chief Medical Officer
Mr. Christopher W. Krueger J.D., MBA
Chief Bus. Officer
Dr. Sheila K. Gujrathi M.D.
Executive Chairperson
Dr. Raju S. Mohan Ph.D.
Founder, Chief Executive Officer & Director
Dr. William J. Sandborn M.D., Ph.D.
Pres & Chief Medical Officer
Dr. Martin Douglas Auster M.D.
Chief Financial Officer

How VTYX did perform over past 52-week?

VTYX's closing price is 1,672.67% higher than its 52-week low of $0.78 where as its distance from 52-week high of $25.00 is -44.48%.

How many employees does VTYX have?

Number of VTYX employees currently stands at 81.

Link for VTYX official website?

Official Website of VTYX is: https://www.ventyxbio.com

How do I contact VTYX?

VTYX could be contacted at phone 760 593 4832 and can also be accessed through its website. VTYX operates from 662 Encinitas Boulevard, San Diego, CA 92024, United States.

How many shares of VTYX are traded daily?

VTYX stock volume for the day was 2.95M shares. The average number of VTYX shares traded daily for last 3 months was 5.85M.

What is the market cap of VTYX currently?

The market value of VTYX currently stands at $995.17M with its latest stock price at $13.87 and 71.75M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	81
Beta	1.24
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	81
Beta	1.24
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

VTYX Company Profile and Key Details

Ventyx Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics